152 related articles for article (PubMed ID: 31359345)
1. Dynamics of D-serine reflected the recovery course of a patient with rapidly progressive glomerulonephritis.
Hesaka A; Yasuda K; Sakai S; Yonishi H; Namba-Hamano T; Takahashi A; Mizui M; Hamase K; Matsui R; Mita M; Horio M; Isaka Y; Kimura T
CEN Case Rep; 2019 Nov; 8(4):297-300. PubMed ID: 31359345
[TBL] [Abstract][Full Text] [Related]
2. Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity.
Nasr SH; D'Agati VD; Park HR; Sterman PL; Goyzueta JD; Dressler RM; Hazlett SM; Pursell RN; Caputo C; Markowitz GS
Clin J Am Soc Nephrol; 2008 May; 3(3):682-90. PubMed ID: 18287252
[TBL] [Abstract][Full Text] [Related]
3. ANCA-associated glomerulonephritis/systemic vasculitis in childhood: clinical features-outcome.
Siomou E; Tramma D; Bowen C; Milford DV
Pediatr Nephrol; 2012 Oct; 27(10):1911-20. PubMed ID: 22648163
[TBL] [Abstract][Full Text] [Related]
4. Correlation between Pathological Findings and the Usefulness of Clinical Guidelines for the Treatment of ANCA-Positive RPGN: A Retrospective Analysis.
Yamada T; Kashiwagi T; Shimizu A; Tsuruoka S
J Nippon Med Sch; 2018; 85(5):259-264. PubMed ID: 30464142
[TBL] [Abstract][Full Text] [Related]
5. Rapidly progressive glomerulonephritis: current and evolving treatment strategies.
Little MA; Pusey CD
J Nephrol; 2004; 17 Suppl 8():S10-9. PubMed ID: 15599880
[TBL] [Abstract][Full Text] [Related]
6. [Case of rapidly progressive glomerulonephritis with anti-glomerular basement membrane antibody in the course of MPO-ANCA-associated pachymeningitis].
Yamazaki C; Arai S; Tamura Y; Suzuki Y; Nakajima H; Kojima K; Uchida S
Nihon Jinzo Gakkai Shi; 2009; 51(4):490-5. PubMed ID: 19601559
[TBL] [Abstract][Full Text] [Related]
7. Rapidly progressive glomerulonephritis due to systemic lupus erythematosus and ANCA-associated vasculitis overlap.
Farah RI; Shahin NA; Alawneh M; Adwan M
Lupus; 2020 Jul; 29(8):983-986. PubMed ID: 32316845
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic plasma exchange for the treatment of rapidly progressive glomerulonephritis.
Kaplan AA
Ther Apher; 1997 Aug; 1(3):255-9. PubMed ID: 10225749
[TBL] [Abstract][Full Text] [Related]
9. Improvements in treatment strategies for patients with antineutrophil cytoplasmic antibody-associated rapidly progressive glomerulonephritis.
Hotta O; Ishida A; Kimura T; Taguma Y
Ther Apher Dial; 2006 Oct; 10(5):390-5. PubMed ID: 17096692
[TBL] [Abstract][Full Text] [Related]
10. MPO-ANCA-positive anti-glomerular basement membrane antibody disease successfully treated by plasma exchange and immunosuppressive therapy.
Murakami T; Nagai K; Matsuura M; Kondo N; Kishi S; Araoka T; Kishi F; Sakiyama T; Mima A; Bando Y; Abe H; Doi T
Ren Fail; 2011; 33(6):626-31. PubMed ID: 21599422
[TBL] [Abstract][Full Text] [Related]
11. Crescentic glomerulonephritis in children.
Mayer U; Schmitz J; Bräsen JH; Pape L
Pediatr Nephrol; 2020 May; 35(5):829-842. PubMed ID: 32052153
[TBL] [Abstract][Full Text] [Related]
12. Diabetes mellitus associated with rapidly progressive glomerulonephritis with perinuclear antineutrophil cytoplasm antibodies.
Takeshita Y; Takagi N; Yamada A; Aikawa T; Umemura S
Intern Med; 2000 Feb; 39(2):154-6. PubMed ID: 10732835
[TBL] [Abstract][Full Text] [Related]
13. Identification of biomarkers that predict response to treatment of lupus nephritis with mycophenolate mofetil or pulse cyclophosphamide.
Dall'Era M; Stone D; Levesque V; Cisternas M; Wofsy D
Arthritis Care Res (Hoboken); 2011 Mar; 63(3):351-7. PubMed ID: 21080348
[TBL] [Abstract][Full Text] [Related]
14. Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies.
Pradhan VD; Badakere SS; Bichile LS; Almeida AF
J Assoc Physicians India; 2004 Jul; 52():533-7. PubMed ID: 15645975
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy of intravenous immunoglobulin for patients with MPO-ANCA-associated rapidly progressive glomerulonephritis.
Ito-Ihara T; Ono T; Nogaki F; Suyama K; Tanaka M; Yonemoto S; Fukatsu A; Kita T; Suzuki K; Muso E
Nephron Clin Pract; 2006; 102(1):c35-42. PubMed ID: 16174989
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of prognostic factors for myeloperoxidase anti-neutrophil cytoplasmic antibody- (MPO-ANCA) associated glomerulonephritis.
Okano K; Yumura W; Nitta K; Honda K; Uchida K; Nihei H
Clin Nephrol; 2001 Apr; 55(4):275-81. PubMed ID: 11334312
[TBL] [Abstract][Full Text] [Related]
17. A case of membranous nephropathy diagnosed with lupus nephritis 11 years after onset.
Yamada T; Itagaki F; Aratani S; Kawasaki S; Terada K; Mugishima K; Kashiwagi T; Shimizu A; Tsuruoka S
CEN Case Rep; 2019 Nov; 8(4):301-307. PubMed ID: 31399881
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of rapidly progressive lupus nephritis associated with anti-MPO antibodies by intravenous immunoglobulins.
Arahata H; Migita K; Izumoto H; Miyashita T; Munakata H; Nakamura H; Tominaga M; Origuchi T; Kawabe Y; Hida A; Taguchi T; Eguchi K
Clin Rheumatol; 1999; 18(1):77-81. PubMed ID: 10088959
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of multitarget therapy with cyclophosphamide and tacrolimus for lupus nephritis: a prospective, single-arm, single-centre, open label pilot study in Japan.
Sakai R; Kurasawa T; Nishi E; Kondo T; Okada Y; Shibata A; Nishimura K; Chino K; Okuyama A; Takei H; Nagasawa H; Amano K
Lupus; 2018 Feb; 27(2):273-282. PubMed ID: 28683654
[TBL] [Abstract][Full Text] [Related]
20. Treatment of rapidly progressive glomerulonephritis by extracorporeal immunoadsorption, prednisolone and cyclophosphamide.
Palmer A; Cairns T; Dische F; Gluck G; Gjorstrup P; Parsons V; Welsh K; Taube D
Nephrol Dial Transplant; 1991; 6(8):536-42. PubMed ID: 1956551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
